Libby Jones is the Program Director of Global Health Advocacy Incubator, GHAI’s Overdose Prevention Initiative. Libby leads the Initiative’s advocacy efforts, advancing federal policies to reduce the overdose death rate in the United States by expanding access to treatment and promoting harm reduction. Prior to joining GHAI, Libby served as government relations officer at the Pew Charitable Trusts’ substance use prevention and treatment initiative. Libby also has more than 15 years of experience working in the U.S. federal government, having held various positions in the U.S. Food and Drug Administration, Department of Commerce, Department of Justice.
Libby holds a Masters Degree in Human Rights from the London School of Economics and Political Science, and received a Bachelor of Arts degree from the College of William and Mary.
It can be confusing…. parents tell kids not to use drugs, but we also teach that we should not stigmatize drugs… are sending mixed...
High potency THC is associated with psychosis and schizophrenia. Why are we not following the science? Elizabeth ‘Libby’ Stuyt, MD Dr. Stuyt is a...
What is the difference between marijuana sold at a dispensary and marijuana used for research? There is a big difference? Listen to the world's...